The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Allyl-1-(4-allyl-2-methoxyphenoxy)-2-ethoxy-3-methoxybenzene ID: ALA4514004
PubChem CID: 155539097
Max Phase: Preclinical
Molecular Formula: C22H26O4
Molecular Weight: 354.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CCc1ccc(Oc2cc(CC=C)cc(OC)c2OCC)c(OC)c1
Standard InChI: InChI=1S/C22H26O4/c1-6-9-16-11-12-18(19(13-16)23-4)26-21-15-17(10-7-2)14-20(24-5)22(21)25-8-3/h6-7,11-15H,1-2,8-10H2,3-5H3
Standard InChI Key: ZMFZQYAMPBNHEX-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
33.9079 -3.3719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9067 -4.1914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6148 -4.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3245 -4.1910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3216 -3.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6130 -2.9630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0278 -2.9570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.7370 -3.3630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7368 -4.1778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4452 -4.5837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1523 -4.1724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1466 -3.3510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4376 -2.9488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4303 -2.1317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1343 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6106 -2.1459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2001 -2.9635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.1999 -2.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6146 -5.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9068 -5.8260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1992 -5.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8621 -4.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8663 -5.3945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1607 -5.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3170 -1.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3146 -0.9180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
13 14 1 0
14 15 1 0
6 16 1 0
1 17 1 0
17 18 1 0
3 19 1 0
19 20 1 0
20 21 2 0
11 22 1 0
22 23 1 0
23 24 2 0
16 25 1 0
25 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.45Molecular Weight (Monoisotopic): 354.1831AlogP: 5.35#Rotatable Bonds: 10Polar Surface Area: 36.92Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.55CX LogD: 5.55Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: 0.24
References 1. Ferreira DD, Sousa FS, Costa-Silva TA, Reimão JQ, Torrecilhas AC, Johns DM, Sear CE, Honorio KM, Lago JHG, Anderson EA, Tempone AG, Tempone AG.. (2019) Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi., 176 [PMID:31103897 ] [10.1016/j.ejmech.2019.05.001 ] 2. de Sousa FS,Baldim JL,Azevedo RA,Figueiredo CR,Pieper P,Sear CE,Anderson EA,Lago JHG. (2020) Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design., 30 (16): [PMID:32631547 ] [10.1016/j.bmcl.2020.127349 ]